Logo of Huzzle

2024 Summer Intern - Machine Learning UK

image

Inflammatix, Inc.

Mar 13, 2024

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Data
  • Cambridge

Requirements

  • Qualifications and Skills:
  • Exceptional ability to work independently in a remote-only environment.
  • A playful and positive attitude, and eagerness to chip in wherever needed.
  • Self-confidence, humility, maturity, and self-motivation to take on substantial responsibility.
  • Keen attention to detail, and the ability to be resourceful and solve problems.
  • Ability to prioritize and manage numerous tasks quickly, accurately, and efficiently.
  • Exceptional oral, written, and interpersonal communication skills.
  • An interest in the in-house legal environment with a focus on the life sciences.
  • Application Requirements:
  • Resume
  • Writing Sample (3 pages or less, excerpts okay)
  • Personal statement discussing how this opportunity will further your legal aspirations (500 words or less)

Responsibilities

  • Research, develop and implement statistical and machine learning methods (existing or novel) based on gene expression and clinical data
  • Keep abreast of current statistical/ML literature and share relevant work and insights with the ML research group and the greater Inflammatix informatics team
  • Engage proactively across disciplinary boundaries with relevant teams/entities at Inflammatix, Inc. surrounding (but not limited to) biomarker discovery, deployment, and other aspects of product development.

We’re reimagining diagnostics by reading the immune system

Science & Healthcare
Industry
51-200
Employees
2016
Founded Year

Mission & Purpose

Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response diagnostics. Our test rapidly informs the clinician about the likelihood of bacterial or viral infection and the need for ICU level care in the emergency department. Faster results may translate into more timely and appropriate therapy and level of care decisions. *Products in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.